✦ LIBER ✦

Phase II randomised trial of docetaxel (D), estramustine (E) and prednisone (P) — Two schedules — versus mitoxantrone (M) and prednisone in patients (PTS) with hormone refractory prostate cancer (HRPC)

✍ Scribed by S. Qudard; E.B. Banu; E. Voog; H. Hardy-Bessard; C. Linassier; P. Beuzeuboe; A. Banu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

299 POSTER Randomized phase II trial of

✍ L. Hart; J. Hainsworth; T. Ciuleanu; S. Oudard; E. Berger; J. Alexandre; K. Chi; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Docetaxel (D), estramustine (E), dexamet

✍ Sergio Bracarda; Paolo Lippe; Antonio Contu; Francesca Marrocolo; Verena De Ange 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Phase II study of sequential chemotherap

✍ Galli, L; Fontana, A; Galli, C; Landi, L; Fontana, E; Antonuzzo, A; Andreuccetti 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

IMPACT OF DOCETAXEL (D) – BASED CHEMOTHE

✍ O. Caffo; T. Sava; E. Comploj; Z. Zustovich; R. Segati; A. Fariello; A. Perin; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

899 PUBLICATION A phase II study of sequ

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

305 RESULTS OF A MULTICENTRIC PHASE II R

✍ O. Caffo; E. Comploj; T. Sava; G. Mansueto; F. Zustovich; R. Segati; C. Sacco; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 316 KB